CardioGenics Holdings Inc banner

Intrinsic Value

CGNH latest financial reports are more than 6 years old.
Not Available for CGNH

There is not enough data to reliably calculate the intrinsic value for CardioGenics Holdings Inc.

Do our valuations actually work? See backtest results .

Alternatives to CGNH

Fundamental Analysis

What CardioGenics Does

Biotechnology Health Care

CardioGenics Holdings, Inc. is a biotechnology company, which engages in the business of development and commercialization of diagnostic test products to the In Vitro Diagnostics testing market. The company is headquartered in Boca Raton, Florida. The company went IPO on 2004-06-09. The firm has developed the QL Care Analyzer, a point-of-care immuno-analyzer, which is capable of running approximately 200+immunoassay diagnostic tests, such as cardiovascular diagnostic tests.

Headquarters
United States of America US
IPO date
Jun 9, 2004
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
CardioGenics Holdings Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape